| payload |
{"created_at":"2026-04-21T03:09:54.871 {"created_at":"2026-04-21T03:09:54.871544+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:706ac50e1de1cfee","evidence_event_ids":["evt_87289fb3013e"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/883241/0001193125-26-164085.txt","as_of":"2026-04-21T03:09:54.871544+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/883241/0001193125-26-164085.txt","company":"SYNOPSYS INC","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/883241/0001193125-26-164085.txt","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_77df2dddcc77b3d4","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/883241/0001193125-26-164085.txt","content_type":"text/plain","enriched_at":"2026-04-21T09:11:31.521109+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"8-K","final_url":"https://www.sec.gov/Archives/edgar/data/883241/0001193125-26-164085.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/883241/0001193125-26-164085.txt","source_event_id":"evt_87289fb3013e","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"8-K","fp":"4dabe90d8d3f2ac3","kind":"sec_filing","published_at":"20260420","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-16","2026-04-20","2026-04-21","2026-02-17","2026-02-19","2026-02-02","2026-10-31"],"entities":[{"asset_class":"equity","name":"Synopsys, Inc.","relevance":"high","symbol":"SNPS","type":"issuer"},{"asset_class":"other","name":"KPMG LLP","relevance":"medium","symbol":"","type":"auditor"},{"asset_class":"other","name":"Synopsys Board of Directors","relevance":"medium","symbol":"","type":"governance body"},{"asset_class":"other","name":"Compensation and Organizational Development Committee of the Board","relevance":"low","symbol":"","type":"committee"}],"event_type":"listing","information_gaps":["The filing\u2019s specific SEC Item numbers beyond the text shown are not fully enumerated (the excerpt references Item 5.02(e) but does not show the full item headings).","The excerpt does not include the detailed vote counts/percentages for each proposal (it states results are set forth below, but the numeric results are not present in the provided text).","No explicit guidance or financial implications are stated in the provided excerpt beyond governance/plan approval.","The excerpt does not describe any changes vs a prior known state (e.g., what was amended relative to the prior equity incentive plan) beyond stating it is \u201cAmended and Restated\u201d and that non-employee directors are included as eligible award recipients."],"key_facts":["Form 8-K filed by Synopsys, Inc. (SNPS).","Stockholders approved Synopsys\u2019 Amended and Restated Equity Incentive Plan at the 2026 Annual Meeting held April 16, 2026.","The Equity Incentive Plan was previously approved by Synopsys\u2019 Board and the Compensation and Organizational Development Committee, subject to stockholder approval.","The plan is intended, among other things, to include non-employee directors as eligible persons to receive awards.","A summary of the Equity Incentive Plan is incorporated by reference from Proposal 2 in the definitive proxy statement filed February 19, 2026.","The Equity Incentive Plan is filed as Exhibit 10.1 to the 8-K.","Annual Meeting record date was February 17, 2026; 191,561,935 shares were outstanding and entitled to vote.","A total of 163,586,092 shares (quorum) were represented in person or by proxy at the Annual Meeting.","Five proposals were voted on by stockholders; Proposal 2 was approval of the Equity Incentive Plan.","Proposal 5: stockholders did not approve the stockholder proposal regarding stockholders\u2019 right to act by written consent.","Exhibit 10.1 is titled \u201cSynopsys, Inc. Amended and Restated Equity Incentive Plan,\u201d adopted by the Board February 2, 2026 and approved by stockholders April 16, 2026."],"numeric_claims":[{"label":"Annual Meeting date","value":"April 16, 2026"},{"label":"Record date","value":"February 17, 2026"},{"label":"Shares outstanding entitled to vote","value":"191,561,935"},{"label":"Shares represented (quorum)","value":"163,586,092"},{"label":"Number of directors elected (Proposal 1)","value":"10"}],"primary_claim":"Synopsys\u2019 stockholders approved the Amended and Restated Equity Incentive Plan at the April 16, 2026 Annual Meeting, and the plan is filed as Exhibit 10.1 to the 8-K.","relevance_score":0.62,"sentiment":"neutral","source_quality":"high","summary":"Synopsys filed a Form 8-K reporting stockholder approval of an Amended and Restated Equity Incentive Plan at its April 16, 2026 Annual Meeting, along with annual meeting results for five proposals. The filing also includes the Equity Incentive Plan as Exhibit 10.1.","topics":["8-K","Annual Meeting Results","Equity Incentive Plan","Stockholder Proposals","Exhibit 10.1","Corporate Governance"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 8-K \u00b7 SYNOPSYS INC \u00b7 Filed 20260420","ticker":"SNPS","tickers":["SNPS"],"title":"SNPS filed 8-K","url":"https://www.sec.gov/Archives/edgar/data/883241/0001193125-26-164085.txt"}}... |